CEA-based DNA vaccine (Vanderbilt/Scripps)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCEA-based DNA vaccine (Vanderbilt/Scripps)
Drug Alias Namecolon cancer vaccine (Scripps/Vanderbilt)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Scripps Research Institute IncVanderbilt University
Active IndicationsN/A
Inactive IndicationsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A